Therapeutic Asset Ratings
137 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Dostarlimab
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Encequidar
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Fianlimab
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Gsk 5733584
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Inetetamab
Breast Neoplasms
Henan Cancer Hospital
P2
CCC
(48)
Irx 2
Breast Neoplasms
Providence Health & Services
P2
CCC
(48)
Ladiratuzumab Vedotin
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Lasofoxifene
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Lomustine
Breast Neoplasms
Actuate Therapeutics Inc.
P2
CCC
(48)
MIDAZOLAM
Breast Neoplasms
Pfizer
P2
CCC
(48)
N-DESMETHYL-4-HYDROXYTAMOXIFEN
Breast Neoplasms
Atossa Therapeutics, Inc.
P2
CCC
(48)
Niraparib
Breast Neoplasms
Tempus AI
P2
CCC
(48)
Pemigatinib
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P2
CCC
(48)
Pexidartinib
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Pyrotinib
Breast Neoplasms
Second Affiliated Hospital of Soochow University
P2
CCC
(48)
Rilvegostomig
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Sarilumab
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Tirzepatide
Breast Neoplasms
Baylor Research Institute
P2
CCC
(48)
Toripalimab
Breast Neoplasms
RemeGen Co., Ltd.
P2
CCC
(48)
Trastuzumab Duocarmazine
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Veliparib
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
vv1
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Zanidatamab
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Ganetespib
Breast Neoplasms
QuantumLeap Healthcare Collaborative
P2
CC
(47)
Showing 76 to 100 of 137 assets
Previous
Page 4 of 6
Next